Pharma

iDOMO: New AI tool predicts synergistic drug combinations

Researchers at Mount Sinai have developed iDOMO, a powerful AI tool that predicts synergistic drug combinations for complex diseases like cancer.

Your CBD routine: What is the best time time to take CBD?

Savage Cabbage discusses the perfect CBD routine designed by you.

Cannabis for cancer: Improving sleep and pain tolerance

Could cannabis for cancer become a reality in patient wards? Researchers find the plant can improve sleep, pain, and brain clarity, easing 'chemo brain'.

Why does cannabis give us the “munchies”? Tests on worms could give clues

Researchers looking to see if giving worms cannabinoids alters their existing food preferences find that worms get the “munchies” too.

Why do the effects of an anti-ageing drug differ with gender?

The effect of the anti-ageing drug rapamycin differs in male and female fruit flies, find researchers, who seek to understand how sex influences the development of age-related disease.

Gender gaps in drug trials harm women’s health through overmedication

When conducting drug trials, it is vital to include women and men in research to prevent gender gap issues like adverse drug reactions.

What is the ‘entourage effect’ of cannabis and how can it relieve pain?

The ‘entourage effect’ of cannabis comes from the pain-relieving effects of the plant, but could we boost this pain-relieving efficacy of THC without the psychoactive side effects?

Why Europe needs to catch up with psychedelic research

David Nutt FMedSci, Chair Drug Science and PAREA, Prof of Neuropsychopharmacology at Imperial College London, explains why Europe needs to catch up with psychedelic research.

How clarity and standards can help the CBD Industry to thrive

Michael Sassano, CEO at SOMAÍ Pharmaceuticals, walks us through how clarity and standards can help the CBD Industry to thrive.

Drug combination for children with MYC amplified Medulloblastoma

Researchers discover drug combination that could offer a better prognosis for children diagnosed with MYC amplified Medulloblastoma, an often deadly form of brain cancer.

Hemp & CBD – A legitimate industry framework

Here, Savage Cabbage Ltd argue for a legitimate Industry Framework when it comes to hemp & CBD

Increasing blood-brain barrier permeability with Acoustic Cluster Therapy (ACT®) to enhance drug delivery in the brain

Despite the rising incidence of Central Nervous System diseases worldwide, efficient treatment options for neurological disorders remain scarce. Treatment failures are principally associated with the inability of drugs to pass the highly selective Blood-Brain Barrier rather than a lack of efficacy.

The UK CBD Market: Cannabinoids, Consumers and Confusion

Savage Cabbage Ltd give insight into the UK CBD market, defining the differences in cannabinoid products and their roles in the industry.

What can the UK Government do for access to cannabis and CBD Reform

Pointing to advancements in public health, the UK government can improve access to cannabis by altering its CBD reform.

How cannabis tracking technology can help global supply chain struggles

Lewis Koski, Chief Strategy Officer of Metrc, charts how cannabis tracking technology can help global supply chain struggles.

Germany becomes one of the first European countries to legalise cannabis

Germany has made plans to legalise cannabis, which could create up to 27,000 new jobs and save around about 4.7 billion euros.

Do you really need to be taking paracetamol?

Paracetamol is Britain’s most trusted painkiller with the average person taking up to 70 paracetamol per year, however there are safety issues.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders